NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 156 filers reported holding NEWLINK GENETICS CORP in Q3 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $40,000 | -77.5% | 15,774 | -86.9% | 0.00% | – |
| Q2 2019 | $178,000 | +836.8% | 120,571 | +890.4% | 0.00% | – |
| Q4 2018 | $19,000 | -95.6% | 12,174 | -79.3% | 0.00% | -100.0% |
| Q1 2018 | $427,000 | -55.5% | 58,811 | -37.6% | 0.00% | -75.0% |
| Q3 2017 | $959,000 | +514.7% | 94,183 | +343.0% | 0.00% | +300.0% |
| Q2 2017 | $156,000 | -55.0% | 21,259 | +47.6% | 0.00% | -50.0% |
| Q1 2017 | $347,000 | -86.8% | 14,400 | -93.9% | 0.00% | -84.6% |
| Q2 2016 | $2,637,000 | +7.1% | 234,200 | +73.1% | 0.01% | 0.0% |
| Q1 2016 | $2,463,000 | -8.0% | 135,326 | +83.9% | 0.01% | -23.5% |
| Q4 2015 | $2,677,000 | +132.0% | 73,577 | +128.4% | 0.02% | +142.9% |
| Q3 2015 | $1,154,000 | -60.5% | 32,208 | -51.2% | 0.01% | -63.2% |
| Q2 2015 | $2,920,000 | +4.2% | 65,947 | +28.8% | 0.02% | -13.6% |
| Q1 2015 | $2,802,000 | – | 51,204 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |